Digital x-ray, multislice CT, and PACS highlight new technology developmentsA robust medical imaging market didn’t slow the growing trend toward consolidation among companies exhibiting at December’s Radiological Society of North America
Digital x-ray, multislice CT, and PACS highlight new technology developments
A robust medical imaging market didnt slow the growing trend toward consolidation among companies exhibiting at Decembers Radiological Society of North America meeting in Chicago. Acquisitions caused several once-familiar names to either change their corporate ownership or disappear entirely from the conferences technical exhibit floor. The moves occurred despite the fact that the U.S. medical imaging market posted its second consecutive year of strong revenue growth in 1998.
No fewer than five major acquisitions closed in the weeks prior to the RSNA meeting, keeping booth staffs busy changing signage and getting the word out. The deals included GEs purchase of Marquette Medical, GEs acquisition of Elscints MRI and nuclear medicine businesses, Pickers purchase of Elscints CT unit, Kodaks acquisition of Imations medical operations, and Access Radiologys purchase of teleradiology firm EMED. Two other major deals that occurred earlier in the year were GEs purchase of Diasonics Vingmed Ultrasound in April and Philips acquisition of ATL Ultrasound in September.
An uninformed observer might see the frenzied pace of mergers and acquisitions as a sign of trouble in radiology, but nothing could be further from the truth. Major vendors are reporting across-the-board growth in equipment sales, with some modalities on course to deliver double-digit growth rates by the end of 1998. The gravity-defying MRI market, for example, followed up a banner year in 1997 with another strong performance in 1998. Although final numbers are not yet in, some market watchers believe the U.S. MRI market could hit $1 billion in sales for the year, an all-time sales record.
So what gives with consolidation? Theres no easy answer, but there are some commonalities among the deals. In almost all of the major acquisitions reported in 1998, the vendors doing the buying were trying to round out their portfolios in areas where they were weak. In addition, the companies being acquired either had been experiencing profitability problems or were owned by corporate parents whose commitment to medical imaging was not strong (there were obvious exceptions, such as the cases of ATL and Marquette).
Whether the pace of consolidation continues is anybodys guess. One side might argue that all the best bargains are gone. On the other hand, the spate of mergers and acquisitions has resulted in shifting power dynamics in the market. Some companies on the wrong side of these shifts might believe its necessary to join forces to find the scale required to vie more effectively with their bulked-up competitors.
On the technology side, developments in multislice CT gave proponents of that modality something to cheer about. New digital x-ray systems being launched by several companies succeeded in livening up one of radiologys more staid modalities, while PACS continued its remarkable rise to prominence.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.